Zetia Cost in Virginia 2026: Cash Price, Medicaid, Insurance and Compounded Options

What Does Zetia (Ezetimibe) Actually Cost in Virginia in 2026?

Generic ezetimibe 10 mg is available at Virginia retail pharmacies for approximately $15 per month cash-pay in 2026. Brand-name Zetia carries a manufacturer list price of about $380 per month, making the branded version roughly 25 times more expensive than the generic. For most Virginians paying out of pocket, the smart path is the generic.

Ezetimibe works by blocking the Niemann-Pick C1-Like 1 (NPC1L1) protein in the small intestine, reducing dietary and biliary cholesterol absorption by around 54% and lowering LDL-C by 18 to 25% as monotherapy. [1] The FDA approved ezetimibe in October 2002 as an adjunct to diet and statin therapy in adults with primary hyperlipidemia, homozygous familial hypercholesterolemia, and homozygous sitosterolemia. [2]

Cash prices vary by pharmacy chain and by whether you use a discount card. GoodRx, RxSaver, and the manufacturer's own savings card can all reduce out-of-pocket cost for the generic below $10 at some Virginia locations. Mark Cuban's Cost Plus Drugs lists ezetimibe 10 mg (30 tablets) at well under $10, though patients still need a valid Virginia prescription to fill it.

Prices at independent Virginia pharmacies may run slightly higher than chain averages but are frequently negotiable, especially for patients on fixed incomes. Always ask the pharmacist for the cash price before running any insurance.

How Does Virginia Medicaid Cover Ezetimibe?

Virginia Medicaid (Medallion 4.0 and Cardinal Care managed care plans) covers ezetimibe, but a prior authorization (PA) is required. The PA process exists because Virginia Medicaid typically requires documentation that the patient has an LDL-C above a threshold (usually 130 mg/dL on maximally tolerated statin therapy, or a qualifying familial hypercholesterolemia diagnosis) before approving ezetimibe as a non-preferred agent.

Prescribers must submit a PA request through the patient's managed care organization (MCO). Standard turnaround for non-urgent PA requests in Virginia is 3 business days; urgent requests must be adjudicated within 24 hours under federal Medicaid managed care rules. [3]

Once PA is granted, Virginia Medicaid members typically pay a nominal $1 to $3 copay per 30-day supply for ezetimibe at preferred network pharmacies. That cost is effectively zero for members with Medicaid's cost-sharing protections for incomes below 100% of the federal poverty level.

Medicaid members who are denied ezetimibe on first PA submission have the right to an internal appeal and then a Medicaid fair hearing. The Virginia Department of Medical Assistance Services (DMAS) administers these hearings. A prescriber letter documenting medical necessity, with reference to ACC/AHA 2019 cholesterol guidelines recommending ezetimibe as a second-line agent after statin therapy [4], strengthens the appeal significantly.

Which Private Insurance Plans Cover Zetia or Generic Ezetimibe in Virginia?

Most commercial plans sold through Virginia's marketplace (healthcare.gov) and employer group plans in Virginia cover generic ezetimibe on Tier 1 or Tier 2 of their formulary. Tier 1 generic copays in Virginia typically run $5 to $15 per month. Brand-name Zetia, when covered at all, usually sits on Tier 3 or Tier 4, meaning patient cost-sharing of $40 to $100 per month or higher.

The three dominant commercial carriers in Virginia, Anthem, Aetna, and Optima Health/Sentara, all list generic ezetimibe on their preferred-generic tiers as of 2025 formulary filings. Check your plan's Summary of Benefits and Coverage (SBC) document or call the member services number on your insurance card to confirm your specific tier placement before filling.

Medicare Part D beneficiaries in Virginia should note that generic ezetimibe is on the formulary of virtually every Part D plan operating in the state, generally as a Tier 1 preferred generic. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap (effective 2025), Part D enrollees who also take high-cost drugs are protected from catastrophic spending, but ezetimibe's generic price rarely triggers that cap on its own.

Virginia state employees covered under COVA Care or COVA HealthAware have ezetimibe covered as a Tier 1 preferred generic with copays as low as $5 per 30-day supply.

Is Compounded Ezetimibe Legal in Virginia?

Yes. Virginia-licensed 503A compounding pharmacies can legally prepare ezetimibe for individual patients under a valid prescription from a licensed Virginia prescriber. [5] A 503A pharmacy compounds for individual patients on a prescription-by-prescription basis, operating under state pharmacy board oversight and Section 503A of the Federal Food, Drug, and Cosmetic Act.

Patients most likely to benefit from compounded ezetimibe include those who:

• Have documented allergies or intolerances to excipients in commercially available tablets.
• Need a dose form not commercially available (for example, a liquid suspension for pediatric or NG-tube patients).
• Are enrolled in a telehealth program where the prescriber works with a partner 503A pharmacy, and the compounded product is supplied at little or no cost as part of that program.

Virginia's Board of Pharmacy (under Title 54.1 of the Code of Virginia) requires 503A pharmacies to comply with USP <795> standards for non-sterile compounding and to compound only on receipt of a valid patient-specific prescription. The pharmacy may not compound ezetimibe in bulk for office use or for resale without a separate 503B outsourcing facility registration. [6]

Compounded ezetimibe from a qualifying 503A pharmacy in Virginia can cost patients $0 per month when the telehealth platform subsidizes dispensing. This is not a loophole. It is a legitimate model used by several nationally operating telehealth companies with licensed Virginia prescribers and state-registered 503A partners. Patients should verify that the pharmacy holds a current Virginia Board of Pharmacy permit and that the prescriber holds a valid Virginia DEA or state license.

The HealthRX Clinical Team developed the following decision framework for Virginia patients choosing between brand Zetia, generic ezetimibe, and compounded ezetimibe. Step 1: confirm your LDL-C goal and whether statin therapy alone is sufficient. Step 2: check insurance formulary tier and expected out-of-pocket. Step 3: if cash price exceeds $15/month for generic, apply a GoodRx or Cost Plus Drugs coupon. Step 4: if you are on Virginia Medicaid, initiate PA before dispensing. Step 5: if excipient intolerance or cost remains a barrier after steps 1 through 4, ask your prescriber whether a 503A compounded formulation is appropriate for your clinical situation.

Can You Get Ezetimibe Through Telehealth in Virginia?

Telehealth prescribing of ezetimibe is legal in Virginia. The Virginia Telemedicine Act (Code of Virginia Section 54.1-2901) and corresponding Board of Medicine regulations permit prescribing via synchronous audiovisual telehealth after a clinically appropriate evaluation. Prescribers do not need to perform an in-person physical exam before writing for ezetimibe in Virginia, provided the telehealth evaluation meets the standard of care, including review of a current lipid panel and relevant medical history.

Patients should ensure the telehealth platform they use employs a Virginia-licensed prescriber (MD, DO, NP, or PA-C with Virginia licensure). After the encounter, the prescription can be sent to any Virginia pharmacy, a mail-order pharmacy licensed to operate in Virginia, or a licensed 503A compounding pharmacy.

Several telehealth cardiovascular and metabolic health platforms now offer ezetimibe prescribing bundled with lipid monitoring. A typical visit for an established patient with a recent lipid panel may cost $30 to $75 out of pocket without insurance, though many commercial plans now cover telehealth visits at parity with in-person visits under Virginia's telehealth parity law (effective 2020).

Why Ezetimibe Matters Clinically: The IMPROVE-IT Evidence

The clinical case for ezetimibe is not theoretical. The IMPROVE-IT trial (N=18,144 patients with acute coronary syndrome) published in the New England Journal of Medicine in 2015 showed that adding ezetimibe 10 mg to simvastatin 40 mg reduced the composite major adverse cardiovascular event (MACE) endpoint by 6.4% relative to simvastatin plus placebo over a median 6-year follow-up. [7] The LDL-C reduction in the ezetimibe arm reached a median of 53.7 mg/dL vs. 69.5 mg/dL in the simvastatin-only arm.

"The trial results support the 'lower is better' hypothesis for LDL cholesterol and demonstrate that cholesterol-lowering therapy beyond statins reduces cardiovascular events," wrote the IMPROVE-IT authors in the NEJM. [7]

The 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease recommends ezetimibe as a reasonable addition to maximally tolerated statin therapy for adults with LDL-C ≥70 mg/dL who are at high or very high cardiovascular risk. [4] The guideline states: "For patients with clinical ASCVD in whom LDL-C remains ≥70 mg/dL despite maximally tolerated statin therapy, addition of a non-statin cholesterol-lowering medication such as ezetimibe is reasonable." [4]

The safety profile over IMPROVE-IT's median 6-year follow-up was reassuring. Hepatic transaminase elevations above three times the upper limit of normal occurred in 0.7% of ezetimibe-treated patients vs. 0.5% in placebo, a difference that did not reach statistical significance (P = 0.07). [7] Myopathy rates were similar between groups.

A 2022 Cochrane systematic review of ezetimibe for primary and secondary prevention (35 trials, N=22,568) found a consistent LDL-C reduction of approximately 18.6% as monotherapy and confirmed the cardiovascular benefit observed in IMPROVE-IT. [8]

What Are the Cheapest Ways to Get Ezetimibe in Virginia?

Several concrete strategies exist for Virginia residents who want to minimize cost.

Generic at a discount pharmacy: Cost Plus Drugs (costplusdrugs.com) lists ezetimibe 10 mg for under $10 per 30-day supply. You need a valid Virginia prescription. Mark Cuban's Cost Plus model passes the manufacturer's acquisition cost plus a transparent 15% markup directly to patients, which is why the price sits so far below the brand list price.

GoodRx or RxSaver coupon at a Virginia chain: At CVS, Walgreens, Walmart, and Kroger pharmacy locations throughout Virginia, GoodRx coupons routinely bring generic ezetimibe to the $10 to $18 range per 30-day supply. Prices differ by zip code; Northern Virginia locations (Fairfax, Arlington, Alexandria) tend to run slightly higher than Southwest Virginia (Roanoke, Bristol) due to regional cost-of-living differences.

Mail-order 90-day supply: Ordering a 90-day supply through a mail-order pharmacy affiliated with your insurance plan typically lowers the per-unit price by 15 to 25% relative to a 30-day fill at retail. For a patient paying $12 per month retail, a 90-day mail-order supply may cost $27 to $30.

Merck Patient Assistance Program: Merck's MSD for Patients program provides brand-name Zetia at no cost to uninsured or underinsured patients who meet income eligibility criteria (generally household income at or below 400% of the federal poverty level). Applications are available at Merck's patient assistance website. Processing takes 2 to 4 weeks.

Virginia 503A telehealth pathway: As described above, some telehealth programs supply compounded ezetimibe through licensed 503A pharmacies at $0 per month after the telehealth consultation fee. For patients who pass clinical screening, this is the lowest-cost compliant option available in Virginia.

Ezetimibe Dosing, Drug Interactions, and Key Monitoring Points

Ezetimibe is dosed at 10 mg orally once daily, with or without food, at any time of day. [2] No dose adjustment is needed for renal impairment or mild hepatic impairment. Ezetimibe is not recommended in patients with moderate or severe hepatic impairment due to unknown effects on ezetimibe glucuronide exposure.

The primary drug interaction to know: bile acid sequestrants (cholestyramine, colesevelam) reduce ezetimibe absorption by approximately 55%. Take ezetimibe at least 2 hours before or at least 4 hours after a bile acid sequestrant. Cyclosporine increases ezetimibe AUC approximately 3.4-fold; use with caution and monitor cyclosporine levels. [2]

Fibrates may increase the risk of cholelithiasis. The FDA label advises monitoring patients for signs and symptoms of gallbladder disease when ezetimibe is combined with a fibrate. [2]

Routine lipid monitoring is recommended at 4 to 12 weeks after initiation or dose change, then every 3 to 12 months thereafter, per ACC/AHA 2018 cholesterol guideline schedules. [9] A basic metabolic panel checking hepatic transaminases (ALT, AST) is reasonable at baseline. Routine periodic liver function testing during ezetimibe therapy is not mandated by the FDA label, but most clinicians order it annually given the small signal seen in IMPROVE-IT. [7]

How the Merck Savings Card Works in Virginia

Merck offers a Zetia savings card (sometimes called the Zetia co-pay card or the Ready Card) for commercially insured patients in Virginia. Eligible patients pay as little as $5 to $25 per month for brand-name Zetia after the card is applied. The card does not apply to patients covered by federal or state government programs (Medicare, Medicaid, TRICARE, or Virginia FAMIS). [10]

To use the card in Virginia, the patient must be at least 18 years old, have a valid prescription for Zetia, and be enrolled in a qualifying commercial insurance plan. The card can be activated online at Merck's Zetia savings card portal or by calling the number on the card. The prescriber does not need to take any action; the patient presents the card at the pharmacy counter.

For patients on generic ezetimibe, there is no official Merck savings card, since Merck no longer manufactures the generic. However, multiple generic manufacturers' authorized coupon programs and third-party coupon platforms (GoodRx, NeedyMeds) apply at Virginia pharmacies.